TransMedics Group, Inc.
NASDAQTransMedics Group enters the post-earnings stretch with a battered share price and a wave of sharply lower analyst price targets rewriting the bull case. The catalyst was immediate. The stock fell 6.3% on the week to $94.93, giving back roughly 5.7% over the past month as well. Earnings landed May 5, and the Street's response was swift and unambiguous — four separate analyst target…
Snapshot as of 7 May 2026
TransMedics Group enters the post-earnings stretch with a battered share price and a wave of sharply lower analyst price targets rewriting the bull case. The catalyst was immediate. The stock fell 6.3% on the week to…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TMDX — free to start on ORTEX.
Sign up for free →Open TMDX on ORTEX